×
+ All Categories
Log in
English
Français
Español
Deutsch
The top documents tagged [accelerated approval]
Home >
accelerated approval
Biomarkers and Surrogate Endpoints in Drug Development Technical and Regulatory Considerations Biomarkers and Surrogate Endpoints in Drug Development Technical.
223 views
Surrogate Endpoints: A Regulatory View Greg Campbell, Ph.D. Director, Division of Biostatistics Center for Devices and Radiological Health Food and Drug.
215 views
1 Goals of a Lotronex ® Risk Management Program Toni Piazza-Hepp, Pharm.D. Deputy Director Division of Surveillance, Research and Communication Support.
217 views
Midterm results - Grades B to A+, mostly low A ethical theories14 rising health care costs7 23andme tests13 how are snps assayed4 GWAS6 critical eval of.
215 views
Pain Program Overview
1.093 views
Ucm358301
662 views
Hepatitis C Drugs - Evidence to Demonstrate Effectiveness & Value
337 views
The 5 Most Hated Biotechs: Myriad, Sarepta, OncoMed, VIVUS, and MannKind
4.616 views
Cross Border Corporate and Individual Tax Planning
74 views
Arzerra from approval to post marketing surveillance
71 views
Vaccine Truth
78 views
Melanoma frontline approach
61 views
Next >